https://www.selleckchem.com/pr....oducts/Abitrexate.ht
2%) was obtained for non-neurological purposes. An additional 3,793 claims (8.4%) wherein the test ordered could not be clearly identified were associated with a neurology-related ICD-9 CCS. Conclusions Accurate assessment of genetic testing utilization using claims data is not possible given the high prevalence of nonspecific codes. Reducing the ambiguity surrounding the CPT codes and the actual testing performed will become even more important as more genetic tests become available. Copyright © 2020 The Author(s). Published by Wolt
Like
Comment
Share
